首页|1例D-二聚体高于FDP的原因分析

1例D-二聚体高于FDP的原因分析

扫码查看
目的 报道1例由异嗜性抗体影响,导致患者血浆D-二聚体(D-dimer)高于纤维蛋白(原)降解产物(FDP)的病例,为临床诊疗提供帮助。方法 主要采用更换检测系统的平行试验,多倍稀释试验,异嗜性抗体阻断剂(Heterophilic antibody blocking reagent,HBR)或二硫苏糖醇(dithiothreitol,DTT)处理的方法识别并纠正假性增高的D-二聚体。结果 更换检测系统后,D-二聚体的测定结果在正常范围内;稀释试验提示D-二聚体和稀释倍数之间无线性关系,随着稀释倍数的增加,D-二聚体呈先上升后下降的趋势;HBR或DTT处理后D-二聚体分别为0。60 mg/L FEU、0。50 mg/L FEU,均显著低于初始结果。结论 该病例D-二聚体高于FDP的原因为异嗜性抗体引起的D-二聚体假性增高,可通过更换检测系统、HBR或DTT处理的方法纠正。
One case analysis of cause of D-dimer higher than FDP
Objective This report presents a case in which the patient's plasma D-dimer levels were higher than fibrin-ogen degradation product(FDP)due to the presence of heterophilic antibodies,providing insights for clinical diagnosis and treatment.Methods Parallel testing using a different detection system,serial dilution testing,and interventions such as heterophilic antibody blocking reagent(HBR)or dithiothreitol(DTT)treatment were employed to identify and correct the falsely elevated D-dimer level.Results After changing the detection system,the D-dimer measurements fell within the normal range.Dilution testing showed a non-linear relationship between D-dimer levels and dilution multiples,with D-dimer levels initially increasing and then decreasing with increasing dilution multiples.Following HBR or DTT treatment,D-dimer levels were significantly lower than the initial result,measuring 0.60 mg/L FEU and 0.50 mg/L FEU.Conclusion The cause of elevated D-dimer level above FDP in this case was falsely elevated levels due to heterophilic antibodies,which can be corrected by changing the detection system and employing HBR or DTT treatment.

D-dimerFibrin degradation product(FDP)Heterophilic antibodiesInterference

宋迪、乔莹利、张绮思

展开 >

阜外华中心血管病医院检验科,郑州 450000

D-二聚体 纤维蛋白(原)降解产物 异嗜性抗体 干扰

河南省医学科技攻关计划联合共建项目河南省医学科技攻关计划联合共建项目河南省医学科技攻关计划联合共建项目

LHGJ20210115LHGJ20200081LHGJ20200119

2024

医药论坛杂志
中华预防医学会,河南省医学情报研究所

医药论坛杂志

影响因子:0.47
ISSN:1672-3422
年,卷(期):2024.45(4)
  • 18